
News|Articles|November 1, 2012
Vascepa (Icosapent ethyl)
New molecular entity: FDA approved icosapent ethyl (Vascepa, Amarin Pharmaceuticals Ireland Limited), an ethyl ester of eicosapentaenoic acid (EPA), as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe hypertriglyceridemia.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Growth of GLP-1 therapies has reshaped the market | PBMI 2026
2
Judi Health, Employers Health team up to launch new PBM solution
3
Brandon Kessler on pharmacy pricing under CAA 2026 | PBMI 2026
4
Amy Wadstrom, RPh, on mid-size PBMs and leaving the ‘big three’ | PBMI 2026
5























